PROTAGONIST THERAPEUTICS, INC. (PTGX) Operating income 2016–2025
PROTAGONIST THERAPEUTICS, INC. (PTGX) annual operating income history from SEC filings — each fiscal year as reported.
-$158.1MFY2025 · since FY2016: -$32.7M → -$158.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$158.1M | -162.5% |
| FY2024 | $252.8M | +370.0% |
| FY2023 | -$93.7M | +28.7% |
| FY2022 | -$131.4M | -4.4% |
| FY2021 | -$125.8M | -95.1% |
| FY2020 | -$64.5M | +19.9% |
| FY2019 | -$80.5M | -90.5% |
| FY2018 | -$42.3M | -11.5% |
| FY2017 | -$37.9M | -16.0% |
| FY2016 | -$32.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice